Atrial fibrillation follow-up and secondary prevention

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Conduction
Sinus rhythm
Atrial fibrillation
Atrial fibrillation
Classification and external resources
The P waves, which represent depolarization of the atria, are irregular or absent during atrial fibrillation.
ICD-10 I48.
ICD-9 427.31
DiseasesDB 1065
MedlinePlus 000184
eMedicine med/184  emerg/46

WikiDoc Resources for

Atrial fibrillation follow-up and secondary prevention

Articles

Most recent articles on Atrial fibrillation follow-up and secondary prevention

Most cited articles on Atrial fibrillation follow-up and secondary prevention

Review articles on Atrial fibrillation follow-up and secondary prevention

Articles on Atrial fibrillation follow-up and secondary prevention in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Atrial fibrillation follow-up and secondary prevention

Images of Atrial fibrillation follow-up and secondary prevention

Photos of Atrial fibrillation follow-up and secondary prevention

Podcasts & MP3s on Atrial fibrillation follow-up and secondary prevention

Videos on Atrial fibrillation follow-up and secondary prevention

Evidence Based Medicine

Cochrane Collaboration on Atrial fibrillation follow-up and secondary prevention

Bandolier on Atrial fibrillation follow-up and secondary prevention

TRIP on Atrial fibrillation follow-up and secondary prevention

Clinical Trials

Ongoing Trials on Atrial fibrillation follow-up and secondary prevention at Clinical Trials.gov

Trial results on Atrial fibrillation follow-up and secondary prevention

Clinical Trials on Atrial fibrillation follow-up and secondary prevention at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Atrial fibrillation follow-up and secondary prevention

NICE Guidance on Atrial fibrillation follow-up and secondary prevention

NHS PRODIGY Guidance

FDA on Atrial fibrillation follow-up and secondary prevention

CDC on Atrial fibrillation follow-up and secondary prevention

Books

Books on Atrial fibrillation follow-up and secondary prevention

News

Atrial fibrillation follow-up and secondary prevention in the news

Be alerted to news on Atrial fibrillation follow-up and secondary prevention

News trends on Atrial fibrillation follow-up and secondary prevention

Commentary

Blogs on Atrial fibrillation follow-up and secondary prevention

Definitions

Definitions of Atrial fibrillation follow-up and secondary prevention

Patient Resources / Community

Patient resources on Atrial fibrillation follow-up and secondary prevention

Discussion groups on Atrial fibrillation follow-up and secondary prevention

Patient Handouts on Atrial fibrillation follow-up and secondary prevention

Directions to Hospitals Treating Atrial fibrillation follow-up and secondary prevention

Risk calculators and risk factors for Atrial fibrillation follow-up and secondary prevention

Healthcare Provider Resources

Symptoms of Atrial fibrillation follow-up and secondary prevention

Causes & Risk Factors for Atrial fibrillation follow-up and secondary prevention

Diagnostic studies for Atrial fibrillation follow-up and secondary prevention

Treatment of Atrial fibrillation follow-up and secondary prevention

Continuing Medical Education (CME)

CME Programs on Atrial fibrillation follow-up and secondary prevention

International

Atrial fibrillation follow-up and secondary prevention en Espanol

Atrial fibrillation follow-up and secondary prevention en Francais

Business

Atrial fibrillation follow-up and secondary prevention in the Marketplace

Patents on Atrial fibrillation follow-up and secondary prevention

Experimental / Informatics

List of terms related to Atrial fibrillation follow-up and secondary prevention

Cardiology Network

Discuss Atrial fibrillation follow-up and secondary prevention further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Synonyms and related keywords: AF, Afib, fib

Risk factors for ischemic stroke or systemic embolization in patient with non valvular atrial fibrillation

Numbers represents relative risks[1]

  1. Advanced age (continuous, per decade) 1.4
  2. History of hypertension 1.6
  3. Heart failure or impaired left ventricular systolic function 1.4
  4. Coronary artery disease (CAD) 1.5
  5. Diabetes mellitus (DM) 1.7
  6. Previous stroke or Transient Ischemic Attack (TIA) 2.5

ACC / AHA Guidelines- Recommendation for Pacing to Prevent Atrial Fibrillation (DO NOT EDIT) [2]

Class III

1. Permanent pacing is not indicated for the prevention of AF in patients without any other indication for pacemaker implantation. (Level of Evidence: B)

See Also

Sources

  • The ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities [2]

References

  1. Estes NAM 3rd, Halperin JL, Calkins H, Ezekowitz MD, Gitman P, Go AS, McNamara RL, Messer JV, Ritchie JL, Romeo SJW, Waldo AL, Wyse DG. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with non valvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Performance Measures for Atrial Fibrillation). Circulation 2008; 117:1101–1120
  2. 2.0 2.1 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207

Further Readings

  • Fuster V, Rydén LE, Cannom DS, et al (2006). "ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation 114 (7): e257-354. doi:10.1161/CIRCULATIONAHA.106.177292. PMID 16908781.
  • Estes NAM 3rd, Halperin JL, Calkins H, Ezekowitz MD, Gitman P, Go AS, McNamara RL, Messer JV, Ritchie JL, Romeo SJW, Waldo AL, Wyse DG. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with non valvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Performance Measures for Atrial Fibrillation). Circulation 2008; 117:1101–1120
de:Vorhofflimmernit:Fibrillazione atriale

nl:Boezemfibrillerenno:Atrieflimmerfi:Eteisvärinä


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

related articles